Biotechnology Headlines from PR Newswire

< Go Back

Bina Technologies is acquired by Roche.
Roche acquires Bina Technologies and enters the genomic informatics market
Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference
Cardio3 Biosciences Announces the Enrolment of the 240th Patient for its CHART-1 Phase III Clinical Trial for the Treatment of Heart Failure
Novogen Raises An Additional A$1.75m in Private Placement to US Institutions for Aggregate Private Placement of A$5.85m
Aeterna Zentaris Receives Notification from NASDAQ Relating to Minimum Bid Price
Halozyme Receives European Orphan Drug Designation For PEGylated Recombinant Human Hyaluronidase PH20 For Pancreatic Cancer
Three Somagenics Publications Demonstrate Successful Inhibition of the Hepatitis C Virus by Therapeutic sshRNA™ and Confirm Mechanism of Action
Soligenix Announces Pricing of Public Offering of Units
CHMP Recommends Approval of Xadago™ (Safinamide) to Treat Parkinson´s Disease in the EU
Orexigen's Mysimba™ (naltrexone HCl / bupropion HCl prolonged release) Receives Positive CHMP Opinion Recommending Approval for Weight Management in the European Union
RXi Pharmaceuticals Expands its Clinical Pipeline with an Exclusive Global License for a Second Phase 2 Clinical Compound
Technology Innovations in Smart Fabrics (Technical Insights)
Sorrento and Conkwest Announce Exclusive Global Collaboration
New Possibilities in the Fight Against Pancreatic Cancer
Relmada Therapeutics Announces Results of Annual Shareholders Meeting
ISN Releases Third Edition of US Contractor Health & Safety Performance Indicators Publication Series
U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023
New Chairman Appointed at Egenix, Inc.
Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023
Micro Market Monitor: Global Bio Stimulants in Turf and Ornamentals Market
Micro Market Monitor: Asia-Pacific Clinical Chemistry Market
23andMe Study Sketches Genetic Portrait of the United States
NorthStar Anesthesia Acquires AmSol, Expands Presence in Southeast and Midwest
ABIVAX, a Privileged Partner of the Cuban Life Science Industry, Welcomes Initiative to Renew Relations Between the USA and Cuba
PDS Biotechnology, Inc. Announces Appointment of Biotech Industry Leader Sir Richard Sykes to its Board of Directors as Executive Chairman
Greenspun Appointed to Expanded Role with Deloitte Center for Health Solutions
Biotech Stocks Technical Insight -- ARIAD Pharma, Geron, PDL BioPharma, Cytori Therapeutics, and Navidea Biopharma
$12M Investment in Orphan Drug Company Nutrinia, Brings Hope to Pre-term and Short Bowel Syndrome Infants
Portage's Biohaven Receives Response from FDA to its Pre-IND Meeting Request
Pronutria Biosciences Announces Issuance of Key Patents from USPTO on Compositions and Methods Relating to Oral Biologics
New Report: Decades of Drug Research Failures and Successes Transform Hepatitis C from Incurable to Curable Disease
Published Study Shows Panorama™ NIPT Is Validated To Screen For Microdeletion Syndromes At 9 Weeks Of Pregnancy
Neogen reports 26% increase in net income
SomaGenics Receives $2,275,000 in NIH Funding to Develop its RNAi Therapeutics and microRNA Technologies
Protagonist Therapeutics Names William A. Hodder as Senior Vice President, Corporate Development
Kalorama: Market For Testing On Tissues and Cells Reaches 7.5 Billion-Dollars
HUYA Bioscience International Establishes Alliance with China Wuqing Development Area
Claritas Genomics Appoints Patrick F. Terry as Chief Commercial Officer
D-Pharm Achieves Primary End-point in Phase 2 Clinical Study of THR-18 in Acute Stroke Patients Treated With tPA
Biorem Announces Management Change
Celator® Pharmaceuticals Receives European Patent Allowance on Nanoparticle Delivery Technology
Amgen Announces 30 Percent Increase In 2015 First Quarter Dividend
PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
SQI Diagnostics Reports Fourth Quarter and Fiscal 2014 Results
"Master Regulator" Gene -- Long Tied To Autism Disorders -- Can Stimulate Other Genes Involved In Early Brain Development
Successful FDA Inspection at Hovione
Curemark CEO Delivers Keynote Speech at Epigenetics Conference
First Patient Treated in Mapi Pharma's Phase IIa Clinical Trial of GA Depot for Relapsing Remitting Multiple Sclerosis (RRMS)
BIONOVA asks: Men Skincare is a necessity or a treat?

< Prev Next >
PR Newswire - United Business Media